Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Niva Bupa Q4 Results | Underwriting profit more than triples; gross premiums up 39%
Niva Bupa reported a 65.6% year-on-year rise in net profit for the fourth quarter at ₹341.2 crore, compared with ₹206.1 crore a year ago. Shares of Niva Bupa Health Insurance Company Ltd ended at ₹81.27, up by ₹1.22, or 1.52%, on the BSE today, May 8.
Star Health to launch affordable health insurance plans targeting tier 2, 3 markets
As healthcare expenses soar, Star Health is bracing for premium increases in the next fiscal year. In a proactive move, the insurer is rolling out a series of affordable health insurance options tailored for smaller urban areas. These plans will incorporate a curated list of hospitals to not only streamline costs but also enhance accessibility for policyholders in these communities.

Nippon India Mutual Fund raises stake in this healthcare stock. Do you own? - Mint
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own?Mint
Volumes soar at Niva Bupa Health Insurance Company Ltd counter
Niva Bupa Health Insurance Company Ltd recorded volume of 46.77 lakh shares by 10:47 IST on BSE, a 40.32 times surge over two-week average daily volume of 1.16 lakh shares
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.

GSP Crop Science IPO opens today; should you apply? Here's what brokerages say
Ahead of the issue opening, agrochemical company GSP Crop Science raised ₹120 crore from two anchor investors. Mauritius-based Craft Emerging Market Fund PCC was the largest investor in the anchor book, purchasing nearly 25 lakh shares through two investment vehicles - Citadel Market Fund and Elite Capital Fund - for ₹80 crore. Shine Star Build Cap was the other anchor investor, acquiring 12.5 lakh shares worth ₹40 crore.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Tejas Networks Ltd leads losers in 'A' group
Piramal Pharma Ltd, Northern ARC Capital Ltd, IndusInd Bank Ltd and Amber Enterprises India Ltd are among the other losers in the BSE's 'A' group today, 12 March 2026.
India gains favour with global investors on returns, ESG momentum
India is maturing as a market in which foreign investors who take into account environmental, social and governance (ESG) factors are confident in dedicating more of their portfolio to, according to fund managers at the Indian Venture and Alternate Capital Association conclave in Mumbai, who cite the economy's scale, improving return outlook and advancing ESG standards as key differentiators.

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.